Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg, 3 Blisters each containing 28 Tablets, Rx only, 28 day Regimen, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA., Mahwah, NJ, 07430, NDC 68462-318-29.
Class II · Ongoing
Failed Impurities/Degradation Specifications
Advertisement
Advertisement
Affected lots / codes — check yours against thisBatch number 20230733, Exp Date: October 2025
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ
- Classification
- Class II (temporary or reversible harm possible)
- Status
- Ongoing
- Quantity
- 26,928 packs
- Distribution
- US Nationwide.
- Recall initiated
- September 3, 2025
- Classified
- October 15, 2025
- Initiation
- Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA
enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0021-2026%22
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0021-2026%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots
above against your own product. This page reproduces public FDA data for readability;
EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →